Valproate-induced hyperammonemic encephalopathy without cognitive sequelae: A case report in the psychiatric setting

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 20, Issue 3, 2008, Pages 369-371

  Dealberto, Marie José C C ^a,b   Sarazin, Francine F A ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; OLANZAPINE; VALPROIC ACID;

ADULT; AMMONIA BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; COGNITION; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERAMMONEMIA; LETTER; MANIA; METABOLIC ENCEPHALOPATHY; PRIORITY JOURNAL;

EID: 52649154163     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.2008.20.3.369     Document Type: Letter

References (3)

1. Dealberto MJ: Valproate-induced hyperammonemic encephalopathy: review of 14 cases in the psychiatric setting. Int Clin Psychopharmacol 2007; 22:330-337
2. Eze E, Workman M, Donley B: Hyperammonemia and coma developed by a woman treated with valproic acid for affective disorder. Psychiatr Serv 1998; 49:1358-1359
3. Ricard C, Martin K, Tournier M, et al: A case of parkinsonian syndrome, cognitive impairment and hyperammonemia induced by divalproate sodium prescribed for bipolar disorder. Encephale 2005; 31:98-101